Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review

Swati MehtaLawson Health Research Institute, London, ON, Canada;Parkwood Institute Research, Parkwood Institute, London, ON, Canada;Department of Physical Medicine and Rehabilitation, Western University, London, ON, CanadaCorrespondence[email protected]

Amanda McIntyreLawson Health Research Institute, London, ON, Canada;Parkwood Institute Research, Parkwood Institute, London, ON, Canada

Shannon JanzenLawson Health Research Institute, London, ON, Canada;Parkwood Institute Research, Parkwood Institute, London, ON, Canada

Jerome IruthayarajahLawson Health Research Institute, London, ON, Canada;Parkwood Institute Research, Parkwood Institute, London, ON, Canada

Ali BatemanParkwood Institute Research, Parkwood Institute, London, ON, Canada;Department of Physical Medicine and Rehabilitation, Western University, London, ON, Canada

Robert TeasellLawson Health Research Institute, London, ON, Canada;Department of Physical Medicine and Rehabilitation, Western University, London, ON, Canada

ABSTRACT

Objective: To conduct a systematic review examining the effectiveness of pharmacological management of agitation among individuals with acquired brain injury (ABI).

Data sources: MEDLINE, CINAHL, EMBASE, and PsycINFO databases were searched for all relevant articles published in English from 1980 to January 2016.

Study selection: Studies were included for analysis all participants had moderate to severe ABI, n ≥ 3, and a pharmacological intervention was provided for the treatment of agitation and its effectiveness was assessed.

Data extraction: Data extracted included participant demographics, inclusion and exclusion criteria, study design, outcome measure(s), and results. Study quality was assessed using the Physiotherapy Evidence Database assessment scale for randomized controlled trials (RCTs). A level of evidence was assigned to each intervention using a modified Sackett scale.

Data synthesis: Among 165 retrieved studies, 19 met inclusion criteria. The included studies consisted of 6 RCTs and 13 observational studies. Antipsychotic medications were studied predominately (n = 6), followed by anticonvulsants (n = 4) and dopaminergic (n = 4), antidepressants (n = 3), and beta-blockers (n = 2). Dopaminergic medications, specifically amantadine, had the highest level of evidence (Level 1a). The antipsychotic lithium carbonate was shown to be effective but was not recommended for use due to high risk of neurotoxicity.

Conclusions: Studies consistently demonstrated that pharmacological treatment was effective in reducing agitation post ABI; however, there was insufficient information to develop a conclusion due to the limited number of studies and overall weakness of evidence for each individual medication.

KEYWORDS:

Acknowledgement

We would like to acknowledge Ontario Neurotrauma Foundation for their continued support.

Declaration of interest

The authors report no declarations of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review

Information for

Open access

Opportunities

Help and information

Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review

ABSTRACT

Acknowledgement

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature